Alnylam Pharmaceuticals Inc (ALNY)
243.25
+0.99
(+0.41%)
USD |
NASDAQ |
Dec 24, 16:00
Alnylam Pharmaceuticals Cash and Short Term Investments (Quarterly): 2.780B for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Pfizer Inc | 9.952B |
BridgeBio Pharma Inc | 266.32M |
Gilead Sciences Inc | 5.037B |
Regeneron Pharmaceuticals Inc | 9.796B |
Sarepta Therapeutics Inc | 1.198B |